Blue Pointe Capital Management, LLC Reviva Pharmaceuticals Holdings, Inc. Put Options Transaction History
Blue Pointe Capital Management, LLC
- $149 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RVPH
# of Institutions
40Shares Held
6.88MCall Options Held
256KPut Options Held
77.1K-
Woodline Partners LP San Francisco, CA1.59MShares$1.96 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.24MShares$1.53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.26 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.01MShares$1.25 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT505KShares$620,6580.1% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $25.1M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...